EBMT 2019 | Key challenges of using the intestinal microbiome as a biomarker

Melody Smith

Here, Melody Smith, MD, of Memorial Sloan Kettering Cancer Center, New York, NY, discusses the main challenges that are present when utilizing the intestinal microbiome as a biomarker. Dr Smith was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

Share this video